Summit Investment Advisors »

Rapt Therapeutics shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $72k 2.9k 24.85
2023-09-30 $48k 2.9k 16.62
2023-06-30 $45k 2.4k 18.70
2023-03-31 $44k 2.4k 18.35
2022-12-31 $56k 2.0k 28.28
2022-09-30 $47k 2.0k 23.93
2022-06-30 $30k 1.7k 18.03
2022-03-31 $37k 1.7k 22.24
2021-12-31 $61k 1.7k 36.66
2021-09-30 $52k 1.7k 31.25
2021-06-30 $45k 1.4k 31.94
2021-03-31 $22k 969 22.70
2020-12-31 $19k 969 19.61
2020-09-30 $31k 969 31.99
2020-06-30 $28k 969 28.90
2020-03-31 $3.0k 135 22.22
2019-12-31 $4.0k 135 29.63